These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 6755693

  • 1. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R, Riesen W.
    Schweiz Med Wochenschr; 1982 Sep 25; 112(39):1335-40. PubMed ID: 6755693
    [Abstract] [Full Text] [Related]

  • 2. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A, Mordasini R, Riesen W.
    Dtsch Med Wochenschr; 1983 Mar 11; 108(10):388. PubMed ID: 6337805
    [No Abstract] [Full Text] [Related]

  • 3. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A, Csalánosiné Németh M, Joó I, Kiss E, Havass Z, Szenohradszki P.
    Orv Hetil; 1986 May 11; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract] [Full Text] [Related]

  • 4. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 May 11; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P, Berglund L.
    Miner Electrolyte Metab; 1996 May 11; 22(1-3):16-21. PubMed ID: 8676811
    [Abstract] [Full Text] [Related]

  • 6. [Changes in serum lipoproteins in kidney diseases. Clinical and pathogenetic aspects].
    Walther A, Mordasini R, Riesen W.
    Dtsch Med Wochenschr; 1983 Mar 11; 108(10):385-7. PubMed ID: 6825580
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lipoprotein metabolism in renal replacement therapy: a review.
    Kronenberg F, Dieplinger H, König P, Utermann G.
    Isr J Med Sci; 1996 Jun 11; 32(6):371-89. PubMed ID: 8682643
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
    Nishizawa Y, Shoji T, Kawagishi T, Morii H.
    Kidney Int Suppl; 1997 Nov 11; 62():S90-2. PubMed ID: 9350691
    [Abstract] [Full Text] [Related]

  • 15. [Dyslipoproteinemia: its importance in nephrology].
    Ritz E, Matthias S, Fliser D.
    Z Kardiol; 1993 Nov 11; 82 Suppl 4():49-55. PubMed ID: 8147062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C, Ritter MM, Richter WO, Minkenberg R, Schwandt P.
    Metabolism; 2001 Feb 11; 50(2):166-70. PubMed ID: 11229424
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and classification of dyslipidemia in renal disease.
    Attman PO, Samuelsson O, Alaupovic P.
    Blood Purif; 1996 Feb 11; 14(1):49-57. PubMed ID: 8718566
    [Abstract] [Full Text] [Related]

  • 20. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance.
    Wardle EN, Menon IS, Anderson J.
    Q J Med; 1972 Jan 11; 41(161):15-23. PubMed ID: 5070986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.